HC Wainwright Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: HC Wainwright
Rating: 2.6
Author: MarketBeat

View the latest stock recommendations issued by analysts at HC Wainwright. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from HC Wainwright's equity research team. MarketBeat is not affiliated with or endorsed by HC Wainwright.

36 Analysts
Updated 6/29/2026

Brokerage Ranking: Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Total Ratings: 1,974 Last 12 Months
Buy Ratings: 1,812 Last 12 Months
Sell Ratings: 15 Last 12 Months
Companies Covered: 635 Last 12 Months

Company	Current Price	Report Date	Analyst	Action	Price Target	Rating	Details
INTC Intel	$131.72 +2.6%	6/29/2026		Set Price Target	$150.00		View details for HC Wainwright rating of Intel (NASDAQ:INTC) on 6/29/2026
AMAT Applied Materials	$694.64 +10.8%	6/29/2026		Set Price Target	$850.00		View details for HC Wainwright rating of Applied Materials (NASDAQ:AMAT) on 6/29/2026
PRME Prime Medicine	$3.72 +8.5%	6/29/2026	Arthur He Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	$8.00	Neutral ➝ Buy	View details for HC Wainwright rating of Prime Medicine (NASDAQ:PRME) on 6/29/2026
ALNY Alnylam Pharmaceuticals	$293.52 +0.7%	6/29/2026	Patrick R. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$510.00 ➝ $470.00	Buy	View details for HC Wainwright rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 6/29/2026
MNPR Monopar Therapeutics	$94.56 +7.8%	6/29/2026	Andres Y. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$105.00	Buy	View details for HC Wainwright rating of Monopar Therapeutics (NASDAQ:MNPR) on 6/29/2026
QURE uniQure	$47.39 -0.3%	6/29/2026	Patrick R. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$50.00 ➝ $80.00	Buy	View details for HC Wainwright rating of uniQure (NASDAQ:QURE) on 6/29/2026
ITRG Integra Resources	$2.22 -4.7%	6/26/2026	Heiko F. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Integra Resources (NYSEAMERICAN:ITRG) on 6/26/2026
COAG Hemab Therapeutics	$36.73 +13.5%	6/26/2026	Emily Bodnar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$40.00	Buy	View details for HC Wainwright rating of Hemab Therapeutics (NASDAQ:COAG) on 6/26/2026
OMER Omeros	$9.91 +14.3%	6/26/2026	Brandon Folkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$40.00 ➝ $33.00	Buy	View details for HC Wainwright rating of Omeros (NASDAQ:OMER) on 6/26/2026
IONS Ionis Pharmaceuticals	$80.69 -0.6%	6/25/2026	Mitchell S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$125.00 ➝ $130.00	Buy	View details for HC Wainwright rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 6/25/2026
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
ABSI Absci	$11.35 +4.2%	6/25/2026	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$8.00 ➝ $16.00	Buy	View details for HC Wainwright rating of Absci (NASDAQ:ABSI) on 6/25/2026
ARGX argenex	$912.46 +2.8%	6/25/2026	Douglas Tsao Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$940.00	Buy	View details for HC Wainwright rating of argenex (NASDAQ:ARGX) on 6/25/2026
CNTB Connect Biopharma	$2.38 +8.7%	6/25/2026	Brandon Folkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$7.00	Buy	View details for HC Wainwright rating of Connect Biopharma (NASDAQ:CNTB) on 6/25/2026
GOSS Gossamer Bio	$0.16 +4.5%	6/25/2026	Patrick R. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$5.00 ➝ $2.00	Buy	View details for HC Wainwright rating of Gossamer Bio (NASDAQ:GOSS) on 6/25/2026
USGO U.S. GoldMining	$8.45 +3.0%	6/25/2026	Heiko F. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$30.75	Buy	View details for HC Wainwright rating of U.S. GoldMining (NASDAQ:USGO) on 6/25/2026
ENTX Entera Bio	$1.65 +1.2%	6/24/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Entera Bio (NASDAQ:ENTX) on 6/24/2026
HRMY Harmony Biosciences	$35.34 -0.4%	6/24/2026		Reiterated Rating		Buy	View details for HC Wainwright rating of Harmony Biosciences (NASDAQ:HRMY) on 6/24/2026
CLYM Climb Bio	$13.36 +2.1%	6/24/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$20.00	Buy	View details for HC Wainwright rating of Climb Bio (NASDAQ:CLYM) on 6/24/2026
INCY Incyte	$114.66 +0.8%	6/24/2026	Mitchell S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$140.00	Buy	View details for HC Wainwright rating of Incyte (NASDAQ:INCY) on 6/24/2026
PMN Promis Neurosciences	$10.75 +2.1%	6/24/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$18.00	Buy	View details for HC Wainwright rating of Promis Neurosciences (NASDAQ:PMN) on 6/24/2026
RGNX REGENXBIO	$11.83 +12.9%	6/24/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$26.00	Buy	View details for HC Wainwright rating of REGENXBIO (NASDAQ:RGNX) on 6/24/2026
VSTM Verastem	$3.82 +1.1%	6/24/2026	Andres Y. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$18.00	Buy	View details for HC Wainwright rating of Verastem (NASDAQ:VSTM) on 6/24/2026
MCRB Seres Therapeutics	$7.79 +10.0%	6/23/2026	Matthew Keller Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$12.00	Buy	View details for HC Wainwright rating of Seres Therapeutics (NASDAQ:MCRB) on 6/23/2026
SAFX XCF Global Capital	$0.42 +15.9%	6/23/2026	Amit Dayal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$1.00	Buy	View details for HC Wainwright rating of XCF Global Capital (NASDAQ:SAFX) on 6/23/2026
ENTA Enanta Pharmaceuticals	$14.51 +3.6%	6/23/2026	Brandon Folkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$20.00	Buy	View details for HC Wainwright rating of Enanta Pharmaceuticals (NASDAQ:ENTA) on 6/23/2026
GALT Galectin Therapeutics	$4.97 -0.4%	6/23/2026	Matthew Keller Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$11.00	Buy	View details for HC Wainwright rating of Galectin Therapeutics (NASDAQ:GALT) on 6/23/2026
GMAB Genmab A/S	$26.02 -0.4%	6/23/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$38.00	Buy	View details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 6/23/2026
MCRB Seres Therapeutics	$7.79 +10.0%	6/23/2026	Matthew Keller Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$12.00	Buy	View details for HC Wainwright rating of Seres Therapeutics (NASDAQ:MCRB) on 6/23/2026
ORKA Oruka Therapeutics	$92.49 +2.1%	6/23/2026	Mitchell S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$120.00	Buy	View details for HC Wainwright rating of Oruka Therapeutics (NASDAQ:ORKA) on 6/23/2026
SAFX XCF Global Capital	$0.42 +15.9%	6/23/2026	Amit Dayal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$1.00	Buy	View details for HC Wainwright rating of XCF Global Capital (NASDAQ:SAFX) on 6/23/2026
ZVRA Zevra Therapeutics	$14.01 +3.6%	6/23/2026	Brandon Folkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$26.00	Buy	View details for HC Wainwright rating of Zevra Therapeutics (NASDAQ:ZVRA) on 6/23/2026
CGTX Cognition Therapeutics	$1.09 -2.7%	6/22/2026		Reiterated Rating	$3.00	Buy	View details for HC Wainwright rating of Cognition Therapeutics (NASDAQ:CGTX) on 6/22/2026
LBRX LB Pharmaceuticals	$32.64 +2.3%	6/22/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of LB Pharmaceuticals (NASDAQ:LBRX) on 6/22/2026
MPLT Maplight Therapeutics	$34.30 +3.1%	6/22/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Maplight Therapeutics (NASDAQ:MPLT) on 6/22/2026
BMRN BioMarin Pharmaceutical	$57.67 -2.3%	6/22/2026	Mitchell S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Neutral	View details for HC Wainwright rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 6/22/2026
ACHV Achieve Life Sciences	$6.23 +3.5%	6/22/2026	Brandon Folkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$12.00	Buy	View details for HC Wainwright rating of Achieve Life Sciences (NASDAQ:ACHV) on 6/22/2026
AGMB AgomAb Therapeutics	$17.82 +29.0%	6/22/2026	Patrick R. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$35.00	Buy	View details for HC Wainwright rating of AgomAb Therapeutics (NASDAQ:AGMB) on 6/22/2026
CNXU Conexeu Sciences	$10.24 -6.6%	6/22/2026	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$20.00	Buy	View details for HC Wainwright rating of Conexeu Sciences (NASDAQ:CNXU) on 6/22/2026
FTH Sensei Biotherapeutics	$23.22 +1.5%	6/22/2026	Patrick R. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$60.00	Hold ➝ Buy	View details for HC Wainwright rating of Sensei Biotherapeutics (NASDAQ:FTH) on 6/22/2026
NVCT Nuvectis Pharma	$28.53 +4.9%	6/22/2026	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$13.00 ➝ $39.00	Buy	View details for HC Wainwright rating of Nuvectis Pharma (NASDAQ:NVCT) on 6/22/2026
Read now. Do not delete. You’ve been warned. (Ad) Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change. Don’t be left behind. Click here now.
UUUU Energy Fuels	$14.59 -0.2%	6/22/2026	Heiko F. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$29.00	Buy	View details for HC Wainwright rating of Energy Fuels (NYSEAMERICAN:UUUU) on 6/22/2026
CRM Salesforce	$158.12 -0.2%	6/18/2026		Downgrade		Negative	View details for HC Wainwright rating of Salesforce (NYSE:CRM) on 6/18/2026
CNTB Connect Biopharma	$2.38 +8.7%	6/18/2026		Reiterated Rating	$7.00	Buy	View details for HC Wainwright rating of Connect Biopharma (NASDAQ:CNTB) on 6/18/2026
KPTI Karyopharm Therapeutics	$10.09 -1.2%	6/18/2026	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Karyopharm Therapeutics (NASDAQ:KPTI) on 6/18/2026
QURE uniQure	$47.39 -0.3%	6/18/2026	Patrick R. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of uniQure (NASDAQ:QURE) on 6/18/2026
ALKS Alkermes	$52.53 -4.6%	6/18/2026		Reiterated Rating		Neutral	View details for HC Wainwright rating of Alkermes (NASDAQ:ALKS) on 6/18/2026
RLMD Relmada Therapeutics	$6.98 +4.3%	6/18/2026	Andres Y. Maldonado Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$12.00	Buy	View details for HC Wainwright rating of Relmada Therapeutics (NASDAQ:RLMD) on 6/18/2026
NVCR NovoCure	$15.48 +0.3%	6/18/2026	Emily Bodnar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$48.00 ➝ $46.00	Buy	View details for HC Wainwright rating of NovoCure (NASDAQ:NVCR) on 6/18/2026
OCUL Ocular Therapeutix	$9.90 +0.6%	6/18/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$21.00 ➝ $25.00	Buy	View details for HC Wainwright rating of Ocular Therapeutix (NASDAQ:OCUL) on 6/18/2026
RLMD Relmada Therapeutics	$6.98 +4.3%	6/18/2026	Andres Y. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$12.00	Buy	View details for HC Wainwright rating of Relmada Therapeutics (NASDAQ:RLMD) on 6/18/2026
ANRO Alto Neuroscience	$27.94 +3.3%	6/17/2026	Patrick Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Alto Neuroscience (NYSE:ANRO) on 6/17/2026
SLN Silence Therapeutics	$10.79 +6.4%	6/17/2026	Patrick R. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$75.00	Buy	View details for HC Wainwright rating of Silence Therapeutics (NASDAQ:SLN) on 6/17/2026
COAG Hemab Therapeutics	$36.73 +13.5%	6/17/2026	Emily Bodnar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$40.00	Buy	View details for HC Wainwright rating of Hemab Therapeutics (NASDAQ:COAG) on 6/17/2026
COAG Hemab Therapeutics	$36.73 +13.5%	6/17/2026	Emily Bodnar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$40.00	Buy	View details for HC Wainwright rating of Hemab Therapeutics (NASDAQ:COAG) on 6/17/2026
FF First Mining Gold	C$0.66 -2.9%	6/17/2026		Boost Price Target	C$1.10 ➝ C$1.20		View details for HC Wainwright rating of First Mining Gold (TSE:FF) on 6/17/2026
IRD Opus Genetics	$4.06 +1.5%	6/17/2026	Matthew Caufield Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$8.00	Buy	View details for HC Wainwright rating of Opus Genetics (NASDAQ:IRD) on 6/17/2026
PHAT Phathom Pharmaceuticals	$10.87 +1.4%	6/17/2026	Matthew Caufield Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$26.00	Buy	View details for HC Wainwright rating of Phathom Pharmaceuticals (NASDAQ:PHAT) on 6/17/2026
KRYS Krystal Biotech	$378.15 +1.6%	6/16/2026	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$310.00 ➝ $361.00	Buy	View details for HC Wainwright rating of Krystal Biotech (NASDAQ:KRYS) on 6/16/2026
PHVS Pharvaris	$34.71 +2.1%	6/16/2026		Reiterated Rating		Buy	View details for HC Wainwright rating of Pharvaris (NASDAQ:PHVS) on 6/16/2026
HALO Halozyme Therapeutics	$77.18 +3.0%	6/16/2026	Mitchell S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 6/16/2026
ENGN enGene	$1.78 +1.7%	6/16/2026	Andres Y. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$6.00 ➝ $4.00	Buy	View details for HC Wainwright rating of enGene (NASDAQ:ENGN) on 6/16/2026
GRO Brazil Potash	$2.20 +3.8%	6/16/2026	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$4.75	Buy	View details for HC Wainwright rating of Brazil Potash (NYSEAMERICAN:GRO) on 6/16/2026
EWTX Edgewise Therapeutics	$40.92 -1.3%	6/16/2026	Lander Egaña Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$45.00	Buy	View details for HC Wainwright rating of Edgewise Therapeutics (NASDAQ:EWTX) on 6/16/2026
GRO Brazil Potash	$2.20 +3.8%	6/16/2026	Heiko Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$4.75	Buy	View details for HC Wainwright rating of Brazil Potash (NYSEAMERICAN:GRO) on 6/16/2026
KTTA Pasithea Therapeutics	$0.53 -3.2%	6/16/2026	Sara Nik Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$3.00	Buy	View details for HC Wainwright rating of Pasithea Therapeutics (NASDAQ:KTTA) on 6/16/2026
NMRA Neumora Therapeutics	$1.72 +4.9%	6/16/2026	Douglas Tsao Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$18.00 ➝ $7.00	Buy	View details for HC Wainwright rating of Neumora Therapeutics (NASDAQ:NMRA) on 6/16/2026
BWAY Brainsway	$15.17 +4.8%	6/15/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$17.00	Buy	View details for HC Wainwright rating of Brainsway (NASDAQ:BWAY) on 6/15/2026
NTLA Intellia Therapeutics	$16.61 -0.4%	6/15/2026	Mitchell S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$25.00	Buy	View details for HC Wainwright rating of Intellia Therapeutics (NASDAQ:NTLA) on 6/15/2026
MIRM Mirum Pharmaceuticals	$123.00 -0.6%	6/15/2026	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 6/15/2026
BDSX Biodesix	$23.81 +2.0%	6/15/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$26.00	Buy	View details for HC Wainwright rating of Biodesix (NASDAQ:BDSX) on 6/15/2026
BDSX Biodesix	$23.81 +2.0%	6/15/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$26.00	Buy	View details for HC Wainwright rating of Biodesix (NASDAQ:BDSX) on 6/15/2026
BLTE Belite Bio	$154.65 +4.0%	6/15/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$200.00	Buy	View details for HC Wainwright rating of Belite Bio (NASDAQ:BLTE) on 6/15/2026
CLDX Celldex Therapeutics	$37.44 +6.2%	6/15/2026	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$42.00	Buy	View details for HC Wainwright rating of Celldex Therapeutics (NASDAQ:CLDX) on 6/15/2026
CRNX Crinetics Pharmaceuticals	$36.94 +0.7%	6/15/2026	Douglas Tsao Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$81.00	Buy	View details for HC Wainwright rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 6/15/2026
ELTX Elicio Therapeutics	$4.00	6/15/2026	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$17.00 ➝ $23.00	Buy	View details for HC Wainwright rating of Elicio Therapeutics (NASDAQ:ELTX) on 6/15/2026
IVVD Invivyd	$0.94 +5.8%	6/15/2026	Patrick R. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$10.00	Buy	View details for HC Wainwright rating of Invivyd (NASDAQ:IVVD) on 6/15/2026
SABS SAB Biotherapeutics	$3.90 +2.6%	6/15/2026	Emily Bodnar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$10.00	Buy	View details for HC Wainwright rating of SAB Biotherapeutics (NASDAQ:SABS) on 6/15/2026
NVCT Nuvectis Pharma	$28.53 +4.9%	6/12/2026	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$10.00 ➝ $13.00	Buy	View details for HC Wainwright rating of Nuvectis Pharma (NASDAQ:NVCT) on 6/12/2026
ANIX Anixa Biosciences	$2.85 +2.2%	6/12/2026		Reiterated Rating		Buy	View details for HC Wainwright rating of Anixa Biosciences (NASDAQ:ANIX) on 6/12/2026
SNDX Syndax Pharmaceuticals	$21.78 +2.2%	6/12/2026	Andres Y. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$40.00	Buy	View details for HC Wainwright rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 6/12/2026
HUMA Humacyte	$0.80 +12.7%	6/11/2026	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$3.00 ➝ $4.00	Buy	View details for HC Wainwright rating of Humacyte (NASDAQ:HUMA) on 6/11/2026
OCS Oculis	$13.09 +9.1%	6/11/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Oculis (NASDAQ:OCS) on 6/11/2026
WVE WAVE Life Sciences	$5.68 -2.6%	6/11/2026	Andrew S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of WAVE Life Sciences (NASDAQ:WVE) on 6/11/2026
DMRA Damora Therapeutics, Inc. Common Stock	$24.21 -4.5%	6/11/2026	Mitchell S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$45.00	Buy	View details for HC Wainwright rating of Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) on 6/11/2026
GPCR Structure Therapeutics	$51.69 +4.0%	6/11/2026	Ananda Ghosh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$100.00 ➝ $70.00	Buy	View details for HC Wainwright rating of Structure Therapeutics (NASDAQ:GPCR) on 6/11/2026
ACTU Actuate Therapeutics	$1.58 -6.0%	6/10/2026	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Actuate Therapeutics (NASDAQ:ACTU) on 6/10/2026
LMNR Limoneira	$13.09 -2.5%	6/10/2026		Downgrade		Buy	View details for HC Wainwright rating of Limoneira (NASDAQ:LMNR) on 6/10/2026
ANAB AnaptysBio	$65.97 +4.5%	6/10/2026	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$95.00	Buy	View details for HC Wainwright rating of AnaptysBio (NASDAQ:ANAB) on 6/10/2026
NRIX Nurix Therapeutics	$23.85 +4.1%	6/10/2026	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$32.00	Buy	View details for HC Wainwright rating of Nurix Therapeutics (NASDAQ:NRIX) on 6/10/2026
OMER Omeros	$9.91 +14.3%	6/10/2026	Brandon Folkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$40.00	Buy	View details for HC Wainwright rating of Omeros (NASDAQ:OMER) on 6/10/2026
Trump’s New Currency Reset (Ad) Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 is orchestrating what analyst Porter Stansberry calls a total U.S. money reset, bypassing conventional legal channels under the guise of national security. The last time America reset its currency - under Nixon in the 1970s - it created an average of 1,300 new millionaires a day for over 50 years. Stansberry has identified three asset categories connected to Trump's initiative that could surge, plus his single top investment move. Watch the documentary briefing and find out which side you land on
UEC Uranium Energy	$10.83 +0.3%	6/10/2026	Heiko F. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$26.75	Buy	View details for HC Wainwright rating of Uranium Energy (NYSEAMERICAN:UEC) on 6/10/2026
TNGX Tango Therapeutics	$32.56 +3.5%	6/9/2026	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$27.00 ➝ $66.00	Buy	View details for HC Wainwright rating of Tango Therapeutics (NASDAQ:TNGX) on 6/9/2026
ZVRA Zevra Therapeutics	$14.01 +3.6%	6/9/2026		Reiterated Rating		Buy	View details for HC Wainwright rating of Zevra Therapeutics (NASDAQ:ZVRA) on 6/9/2026
BCDA BioCardia	$1.21 +0.8%	6/9/2026	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$25.00	Buy	View details for HC Wainwright rating of BioCardia (NASDAQ:BCDA) on 6/9/2026
INCY Incyte	$114.66 +0.8%	6/9/2026	Mitchell S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$135.00 ➝ $140.00	Buy	View details for HC Wainwright rating of Incyte (NASDAQ:INCY) on 6/9/2026
LYEL Lyell Immunopharma	$12.75 +9.8%	6/9/2026	Mitchell S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$45.00	Buy	View details for HC Wainwright rating of Lyell Immunopharma (NASDAQ:LYEL) on 6/9/2026
NGNE Neurogene	$32.28 +0.8%	6/9/2026	Mitchell S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$70.00	Buy	View details for HC Wainwright rating of Neurogene (NASDAQ:NGNE) on 6/9/2026
NUVL Nuvalent	$123.51 0.0%	6/9/2026	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	$124.00	Buy ➝ Neutral	View details for HC Wainwright rating of Nuvalent (NASDAQ:NUVL) on 6/9/2026
AMLX Amylyx Pharmaceuticals	$18.70 +5.1%	6/8/2026	Andrew S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$34.00	Buy	View details for HC Wainwright rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 6/8/2026
ADCT ADC Therapeutics	$1.04 +2.4%	6/8/2026	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Buy ➝ Neutral	View details for HC Wainwright rating of ADC Therapeutics (NYSE:ADCT) on 6/8/2026

MarketBeat Community Rating for HC Wainwright

MarketBeat's community ratings are surveys of what our community members think about HC Wainwright and other research firms in the last 90 days. Vote "Outperform" if you believe HC Wainwright's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe HC Wainwright's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.

COMMUNITY RATINGS: 2.6out of 5 (last 90 days)
2.6 of 5 stars
OUTPERFORM VOTES: 9 Believe will outperform the market
UNDERPERFORM VOTES: 8 Believe will underperform the market

Analysts at HC Wainwright

HC Wainwright's equity research team has issued ratings on 629 companies across 17 sectors over the past 12 months, covered by 36 analysts. The HC Wainwright analysts below are listed by number of ratings issued in the last year.

HC Wainwright Stock Coverage by Sector

HC Wainwright concentrates its research most heavily in Medical (71.7%), Basic Materials (6.9%) and Computer and Technology (4.4%). The chart below shows how HC Wainwright's 635 rated companies are distributed across all 17 sectors it covers.

Medical
455 companies
71.7%
Basic Materials
44 companies
6.9%
Computer and Technology
28 companies
4.4%
Manufacturing
25 companies
3.9%
Finance
20 companies
3.1%
Business Services
20 companies
3.1%
Energy
12 companies
1.9%
Industrials
5 companies
0.8%
Financial Services
4 companies
0.6%
Aerospace
4 companies
0.6%
Construction
3 companies
0.5%
Consumer Discretionary
3 companies
0.5%
Auto/Tires/Trucks
2 companies
0.3%
Transportation
2 companies
0.3%
Retail/Wholesale
2 companies
0.3%
Services
1 company
0.2%
Consumer Staples
1 company
0.2%

Best & Worst Calls

Best Call
000000.0%
NASDAQ:NVAX
Initiated Coverage • Jan 22, 2020
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
0000.0%
NASDAQ:EFTR
Reiterated Rating • Nov 14, 2023
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Similarly Rated Firms

HC Wainwright - Frequently Asked Questions

HC Wainwright's analysts currently have buy-equivalent ratings on 591 companies. Recent upgrades to buy include Prime Medicine, Zscaler, Circle Internet Group, BioStem Technologies and Airbnb.

HC Wainwright's highest-rated analysts by MarketBeat's accuracy score include Brandon Folkes, Raghuram Selvaraju and Andrew Fein. Rankings are based on historical rating accuracy and price target precision over the past 12 months. MarketBeat tracks 36 analysts at HC Wainwright.

HC Wainwright has the deepest coverage in Medical (71.7% of rated companies), Basic Materials (6.9% of rated companies), Computer and Technology (4.4% of rated companies), Manufacturing (3.9% of rated companies) and Business Services (3.1% of rated companies).

HC Wainwright issued 1,974 ratings over the last 12 months across 635 companies â€” an average of roughly 164 rating actions per month. These include boost price target, downgrade, initiated coverage, lower price target, reiterated rating, set price target and upgrade. MarketBeat tracks every rating change as it's published so you can see the most current HC Wainwright analyst actions.

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?